STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
249
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · no price filed
What the filings say about PLXS
Insiders, 180 days
-$8.4M net sold
6 sellers · 21% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$2.3M
2 notices
Plexus insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, PLEXUS CORP insiders sold a net $8.4M of stock across 294 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
141 earlier Form 4 trades (code P or S) here by this insider (141 sales), the last on Sep 16, 2026.
The trade is 1.2% of the 63,609 shares held after it.
No other insider sold within 30 days.
249 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Kelsey Todd P. sold about $185.8K of PLXS under a 10b5-1 plan on Oct 21, 2026; 249 funds added in the latest 13F quarter.
141 earlier Form 4 trades (code P or S) here by this insider (141 sales), the last on Sep 16, 2026.
The trade is 1.1% of the 62,888 shares held after it.
No other insider sold within 30 days.
249 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Kelsey Todd P. sold about $173.0K of PLXS under a 10b5-1 plan on Oct 21, 2026; 249 funds added in the latest 13F quarter.
140 earlier Form 4 trades (code P or S) here by this insider (140 sales), the last on Aug 19, 2026.
The trade is 2.3% of the 64,388 shares held after it.
1 other insider sold within 30 days.
249 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Kelsey Todd P. sold about $363.6K of PLXS under a 10b5-1 plan on Sep 16, 2026; 1 other insider sold within 30 days and 249 funds added in the latest 13F quarter.
9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Jun 1, 2026.
The trade is 6.6% of the 7,535 shares held after it.
2 other insiders sold within 30 days.
249 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Rapp Karen Marie sold about $120.4K of PLXS under a 10b5-1 plan on Aug 31, 2026; 2 other insiders sold within 30 days and 249 funds added in the latest 13F quarter.
137 earlier Form 4 trades (code P or S) here by this insider (137 sales), the last on Jul 15, 2026.
The trade is 0.5% of the 67,069 shares held after it.
2 other insiders sold within 30 days.
249 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CEO Kelsey Todd P. sold about $79.4K of PLXS under a 10b5-1 plan on Aug 19, 2026; 2 other insiders sold within 30 days and 249 funds added in the latest 13F quarter.
294 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
PLXS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Todd P. Kelsey
Filed 2026-08-19
$1.2M
SCHROCK MICHAEL V
Filed 2026-08-11
$1.1M
PLXS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
The Disciplined Growth Investors Equity Fund
$9.9M position · as of 2026-07-31
5.7%
Mairs & Power Small Cap Fund
$12.1M position · as of 2026-06-30
4.5%
The Disciplined Growth Investors Fund
$27.1M position · as of 2026-07-31
4.3%
Small-Company Stock Fund
$8.7M position · as of 2026-06-30
4.0%
Invesco S&P SmallCap Information Technology ETF
$14.5M position · as of 2026-05-31
2.7%
Harbor Small Cap Value Fund
$60.2M position · as of 2026-07-31
2.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Kelsey
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$9.1M
$10.3M
$2.9M
+31%
+38%
2022
$7.4M
$8.0M
$2.6M
+23%
+13%
2021
$7.6M
$12.9M
$2.3M
+28%
+36%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $8.4M sold by insiders over 180 days, 249 funds added last quarter, $2.3M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$4.6B
four quarters, 2025-06-29 to 2026-07-04
Revenue, TTM PLXS
FY Sep 2025
$4.0B
FY Sep 2024
$4.1B
FY Sep 2023
$4.3B
FY Oct 2022
$3.9B
FY Oct 2021
$3.5B
Jul 2026
$1.3B
Apr 2026
$1.2B
Jan 2026
$1.1B
Sep 2025
$1.1B
Jun 2025
$1.0B
Mar 2025
$980.2M
Dec 2024
$976.1M
Sep 2024
$1.1B
At each fiscal year end
Single quarter
Net margin, TTM
+4.0%
net income over revenue, 2025-06-29 to 2026-07-04
Net margin, TTM PLXS
FY Sep 2025
+4.3%
FY Sep 2024
+2.7%
FY Sep 2023
+3.2%
FY Oct 2022
+3.5%
FY Oct 2021
+4.0%
Jul 2026
+3.3%
Apr 2026
+4.3%
Jan 2026
+3.8%
Sep 2025
+4.9%
Jun 2025
+4.4%
Mar 2025
+4.0%
Dec 2024
+3.8%
Sep 2024
+3.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
$61.9M
operating cash flow minus capex, 2025-06-29 to 2026-07-04
Free cash flow, TTM PLXS
FY Sep 2025
$154.0M
FY Sep 2024
$341.3M
FY Sep 2023
$61.8M
FY Oct 2022
-$127.9M
FY Oct 2021
$85.5M
Jul 2026
-$754.0K
Apr 2026
$16.0M
Jan 2026
-$50.6M
Sep 2025
$97.2M
Jun 2025
$13.2M
Mar 2025
$16.5M
Dec 2024
$27.1M
Sep 2024
$193.8M
At each fiscal year end
Single quarter
Debt to equity
0.12x
long-term debt only, 2019-09-28 (82 months older than the period end); equity 2026-07-04
Debt to equity PLXS
FY Sep 2025
0.13x
FY Sep 2024
0.14x
FY Sep 2023
0.15x
FY Oct 2022
0.17x
FY Oct 2021
0.18x
Jul 2026
0.12x
Apr 2026
0.13x
Jan 2026
0.13x
Sep 2025
0.13x
Jun 2025
0.13x
Mar 2025
0.14x
Dec 2024
0.14x
Sep 2024
0.14x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.91x
TTM operating cash flow over long-term debt only, 2019-09-28 (82 months older than the period end)
Cash flow to debt PLXS
FY Sep 2025
1.33x
FY Sep 2024
2.33x
FY Sep 2023
0.89x
FY Oct 2022
-0.14x
FY Oct 2021
0.76x
Jul 2026
0.91x
Apr 2026
0.92x
Jan 2026
0.96x
Sep 2025
1.33x
Jun 2025
1.80x
Mar 2025
2.36x
Dec 2024
2.63x
Sep 2024
2.33x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.6%
TTM net income over average of 2025-06-28 and 2026-07-04
Return on equity PLXS
FY Sep 2025
+12.4%
FY Sep 2024
+8.8%
FY Sep 2023
+12.0%
FY Oct 2022
+13.0%
FY Oct 2021
+13.9%
Jul 2026
+12.6%
Apr 2026
+13.2%
Jan 2026
+12.6%
Sep 2025
+12.4%
Jun 2025
+12.1%
Mar 2025
+10.9%
Dec 2024
+9.3%
Sep 2024
+8.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+5.5%
TTM net income over average of 2025-06-28 and 2026-07-04
Return on assets PLXS
FY Sep 2025
+5.5%
FY Sep 2024
+3.5%
FY Sep 2023
+4.1%
FY Oct 2022
+4.7%
FY Oct 2021
+5.8%
Jul 2026
+5.5%
Apr 2026
+5.8%
Jan 2026
+5.7%
Sep 2025
+5.5%
Jun 2025
+5.2%
Mar 2025
+4.5%
Dec 2024
+3.8%
Sep 2024
+3.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+14.4%
operating income after a 13.8% effective tax rate, over long-term debt only, 2019-09-28 (82 months older than the period end) plus average of 2025-06-28 and 2026-07-04 minus cash
Return on invested capital PLXS
FY Sep 2025
+14.9%
FY Sep 2024
+12.5%
FY Sep 2023
+15.7%
FY Oct 2022
+15.9%
FY Oct 2021
+17.7%
Jul 2026
+14.4%
Apr 2026
+15.4%
Jan 2026
+14.6%
Sep 2025
+14.9%
Jun 2025
+14.1%
Mar 2025
+13.6%
Dec 2024
+12.2%
Sep 2024
+12.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+14.1%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-07-04 minus current liabilities
Return on capital employed PLXS
FY Sep 2025
+12.9%
FY Sep 2024
+11.1%
FY Sep 2023
+13.5%
FY Oct 2022
+13.1%
FY Oct 2021
+13.5%
Jul 2026
+14.1%
Apr 2026
+14.1%
Jan 2026
+13.3%
Sep 2025
+12.9%
Jun 2025
+13.4%
Mar 2025
+12.3%
Dec 2024
+11.0%
Sep 2024
+11.1%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
32.79x
close 2026-10-26 over four quarters of diluted EPS, 2025-06-29 to 2026-07-04
P/E, trailing PLXS
FY Sep 2025
22.89x
FY Sep 2024
34.02x
FY Sep 2023
18.82x
FY Oct 2022
17.98x
FY Oct 2021
19.13x
Jul 2026
40.58x
Apr 2026
30.31x
Jan 2026
23.67x
Sep 2025
22.89x
Jun 2025
23.09x
Mar 2025
24.86x
Dec 2024
36.61x
Sep 2024
34.02x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$5.8B
market value at close 2026-10-26 on 2026-08-04 shares, plus long-term debt only, 2019-09-28 (82 months older than the period end), minus cash 2026-07-04
Enterprise value PLXS
FY Sep 2025
$3.7B
FY Sep 2024
$3.6B
FY Sep 2023
$2.5B
FY Oct 2022
$2.3B
FY Oct 2021
$2.5B
Jul 2026
$7.2B
Apr 2026
$5.4B
Jan 2026
$4.0B
Sep 2025
$3.7B
Jun 2025
$3.6B
Mar 2025
$3.3B
Dec 2024
$4.1B
Sep 2024
$3.6B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+1.0%
TTM free cash flow over market value at close 2026-10-26
FCF yield PLXS
FY Sep 2025
+4.0%
FY Sep 2024
+9.2%
FY Sep 2023
+2.4%
FY Oct 2022
-5.3%
FY Oct 2021
+3.3%
Jul 2026
+0.8%
Apr 2026
+1.4%
Jan 2026
+1.9%
Sep 2025
+4.0%
Jun 2025
+6.8%
Mar 2025
+10.2%
Dec 2024
+9.4%
Sep 2024
+9.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
2.12x
P/E over trailing EPS growth of 16%: four quarters to 2026-07-04 against the four to 2025-06-28
PEG, trailing PLXS
FY Sep 2025
0.41x
FY Sep 2024
n/a
FY Sep 2023
13.09x
FY Oct 2022
7.78x
FY Oct 2021
0.89x
Jul 2026
2.62x
Apr 2026
0.92x
Jan 2026
0.48x
Sep 2025
0.41x
Jun 2025
0.48x
Mar 2025
0.59x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
PLXS ranks highest on risk and compliance (73rd percentile) and financial health (71st), and lowest on insider conviction (22nd), among Semiconductors & Electronics peers.
Profitability
70
Inputs
Return on equity+12.6% · 68 pct, sector of 154
Return on assets+5.5% · 66 pct, sector of 171
Return on invested capital+14.4% · 62 pct, sector of 56
Return on capital employed+14.1% · 82 pct, sector of 155
Financial health
71
Inputs
Debt to equity0.12x · 61 pct, sector of 152
Cash flow to debt0.91x · 81 pct, sector of 136
Growth
34
Inputs
Revenue growth, YoY+1.8% · 34 pct, sector of 194
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
22
Inputs
Net Form 4 buying (codes P and S), 180d-$7.1M · 43 pct, sector of 147
Insider buyers, 180d0 · 0 pct, sector of 151
Institutional and government
51
Inputs
Funds adding, latest quarter249 · 70 pct, sector of 184
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$200K · 33 pct, sector of 53
Risk and compliance
73
Inputs
Short interest, % of float+3.5% · 65 pct, sector of 221
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+6.0% · 81 pct, sector of 152
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
PLXS filings, in plain words
Are Plexus insiders buying or selling PLXS?
In the 180 days to 2026-10-28, Plexus insiders were net sellers, a net $8.4M across purchases and sales reported on Form 4, by 6 sellers.
Are there planned insider sales of PLXS?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $2.3M of stock; the latest, by Todd P. Kelsey, was filed 2026-08-19.
Read the full summary
In the 180 days to 2026-10-28, Plexus insiders were net sellers of PLXS, a net $8.4M across purchases and sales reported on Form 4 by 6 sellers. 21% of the 33 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $2.3M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.